This includes regular assessment of weight changes, mood fluctuations, and gastrointestinal tolerance, ensuring the best therapeutic outcomes while minimizing adverse effects through personalized treatment approaches
The findings on how much patients are willing to spend underscore concerns about equity in access to the breakthrough drugs while insurance coverage is sparse
Kessler says, No one tool is going to work for the duration, so having a toolbox of strategies is best
But an assortment of options may pay off, Yanovski says
PlexusDx begins many patients at a conservative dose tier to allow gradual adaptation while still delivering results
You want a clinician who knows your medical history and can talk about risks and benefits, Yanovski says someone who can really follow your health.